Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-05-22 @ 11:20 AM
Study NCT ID:
NCT02757105
Status:
COMPLETED
Last Update Posted:
2018-08-28
First Post:
2016-04-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of BEKINDA (Ondansetron 12 mg Bimodal Release Tablets) for Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Sponsor:
Organization: